Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000714676 | SCV000845396 | uncertain significance | 5-Oxoprolinase deficiency | 2018-08-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000714676 | SCV002789938 | uncertain significance | 5-Oxoprolinase deficiency | 2022-05-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004837775 | SCV005465002 | uncertain significance | not specified | 2024-10-19 | criteria provided, single submitter | clinical testing | The c.2230C>T (p.R744C) alteration is located in exon 16 (coding exon 15) of the OPLAH gene. This alteration results from a C to T substitution at nucleotide position 2230, causing the arginine (R) at amino acid position 744 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |